Configuration drift and its impact on validated systems
Vendor-controlled, customer-controlled, and shared-responsibility changes
Risk-based impact assessments for releases, patches, and feature updates
AI model updates, retraining activities, and algorithm changes
Revalidation, regression testing, and documentation update criteria
FDA CSA principles and GAMP® 5 Second Edition lifecycle guidance
Change control for integrations, APIs, middleware, and connected platforms
Vendor assurance evidence, traceability, approval workflows, and backlog prevention